M&A news

Indo-Borax Acquires KRONOX Lab Sciences in Strategic Deal

Indo-Borax Acquires KRONOX Lab Sciences in Strategic Deal

AcquisitionManufacturingIN

Get the full KRONOX Lab Sciences Limited company profile

Access contacts, investors, buying signals & more

Open in Dashboard
KRONOX Lab Sciences Limited logo
Acquired

KRONOX Lab Sciences Limited

IndiaManufacturing

Undisclosed amount

August 27, 2026

indo-borax- logo
Acquirer

indo-borax-

indo-borax- has acquired KRONOX Lab Sciences Limited for an undisclosed amount. The transaction transfers full ownership of the Gujarat-based specialty chemicals manufacturer to the acquiring company, marking a consolidation in the high-purity fine chemicals sector.

KRONOX Lab Sciences operates a certified manufacturing facility near Vadodara, India, producing high-purity specialty fine chemicals for food, pharmaceutical, and laboratory applications. Its product portfolio spans aluminium, ammonium, barium, boron, calcium, citrates, copper, EDTA derivatives, ferrous, magnesium, potassium, sodium, and zinc salts, among others. The facility holds FSSC 22000, GMP, GLP, and ISO 9001:2008 certifications, with KOSHER and HALAL compliance where applicable. The company’s analytical laboratories support strict quality control across its chemical specifications, which include FCC and food-grade standards, IP, BP, EP, JP, USP monographs for pharmaceuticals, and ACS, AR, GR, and LR grades for reagents.

For indo-borax-, the acquisition broadens its manufacturing footprint and product range beyond its existing operations. The deal brings in-house production capabilities for a wider spectrum of high-purity chemicals, particularly in the borate and non-borate segments, allowing the combined entity to serve a more diverse customer base across food, pharma, and industrial markets. KRONOX’s certified facility and experienced production team are expected to complement indo-borax-’s existing distribution and supply chain strengths.

The acquisition also provides indo-borax- with direct access to KRONOX’s established quality systems and documentation practices, which align with international regulatory requirements. This is likely to support the combined company’s ability to meet stringent specifications for export-oriented clients. The deal does not involve any external funding or investment round; it is a straightforward purchase of the target company’s equity and assets.

Post-acquisition, the combined entity is positioned to expand its specialty chemical offerings while maintaining the certifications and quality standards that KRONOX has built. Integration of production schedules and quality protocols will be a near-term focus, with the aim of leveraging the enlarged portfolio to strengthen market presence in both domestic and international supply chains.

No buying signals identified yet.

Unlock GTM signals

Discover KRONOX Lab Sciences Limited's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at KRONOX Lab Sciences Limited.

Unlock decision-makers
Indo-Borax Acquires KRONOX Lab Sciences in Strategic Deal | M&A News | Signalbase